Calypte Biomedical Corporation reported that its fast, oral HIV diagnostic test has passed the technical review part of the SFDA approval process for use in China. The Aware™ HIV-1/2 OMT, which tests for both HIV-1 and HIV-2, now has just one aspect of the approval process left before final approval: it must prove that it is in conformity with the regulations for products standards and labeling. More details... 

Stock Symbol: (OTCBB: CBMC)